Coronavirus
Japanese researchers eye COVID treatment derived from stem cells
Immunotherapy creates killer T cells that detect coronavirus markers
Talks extended amid divisions between rich and poorer countries
Tally could top 10,000 in fiscal 2024 as cost pressure rises
U.S., Europe and Japan balk over potential burden on drugmakers
After COVID delay, landmark casino resort to start hotel expansion next year
COVID impact has passed but pilot recruitment remains tricky
Drugmaker looks overseas for Xocova sales growth as public funds dry up at home
Despite PM's dithering, empowered local governments delivered effective help
Southeast Asia asks public to mask up and get vaccinated as travel season begins
Some fear government crackdowns have robbed city of what made it great
Nikkei/FT conference address touts 'One Health approach,' multiple sectors working for public benefit
'Medical gold' alternative slow to emerge despite concern over extraction methods
City-state taps biometrics as Hong Kong, Japan also implement smooth procedures
Prices up 30% from before pandemic as weak yen draws in foreign tourists
Eased COVID measures, talent recruitment efforts help reverse decline
July CPI took a 0.3% year-on-year fall, the first in more than two years
Medicines and equipment hit by weak demand amid slow global recovery
Record youth unemployment after Beijing clampdown on private sector, FDI slump
Nearly 3,000 people on waiting list as COVID changes lifestyles
First ever population drop in 2022 as COVID-19 and new policies take toll
Land along major roads becomes more expensive as tourists return after pandemic
More local governments get serious about helping visitors in event of earthquake
Jens Eskelund says market access, clear regulation key for European companies
Prices rise as overseas visitors lead recovery in alternative lodgings
School closures pick up across country after disease spreads at festivals
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.